Selecting the Right Radiopharmaceutical CDMO to De-Risk Development, Scale Manufacturing & Support Long- Term Commercial Success

Name: Selecting the Right Radiopharmaceutical CDMO to De-Risk Development, Scale Manufacturing & Support Long- Term Commercial Success
Start: 2026-12-02T14:00
Location: Renaissance London Heathrow Hotel

Targeted Radiopharmaceuticals Summit EU 2026 · 2 December 2026 · 14:00

Selecting the Right Radiopharmaceutical CDMO to De-Risk Development, Scale Manufacturing & Support Long- Term Commercial Success was a session at Targeted Radiopharmaceuticals Summit EU 2026 on 2 December 2026 in London, with 1 speaker on record.

Speakers

Mark Dornan — Speaker Vice President of Pharmaceutical Development and External Manufacturing, Alpha-9 Oncology